Compare ARK Genomic Revolution ETF (ARKG) vs Mongodb Inc (MDB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Mongodb Inc — how do they compare? ARK Genomic Revolution ETF trades at $40.89, while Mongodb Inc trades at $338.97 (market cap $27.51B). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Mongodb Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | MDB | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $43.57 | $440.25 |
52-Week Low | $23.09 | $201.08 |
Market Cap | — | $27.51B |
Enterprise Value | — | $25.12B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
MongoDB (MDB) trades at $342.08, down 5.73% in the latest session, amid mixed technical signals with a bullish moving average trend but overbought RSI readings. The company shows strong revenue growth, reaching $2.01B in 2025, with consistent earnings beats in recent quarters, though it remains unprofitable with a net margin of -1.12%. Recent news highlights AI-driven demand boosting database sales and raised FY2027 revenue guidance to $2.92–$2.96B.
Outlook remains positive with 82% analyst buy ratings and a $400.39 consensus target, offering ~17% upside. Key risks include ongoing profitability challenges, competitive pressures, and legal scrutiny over fiduciary duties. Revenue growth and AI adoption present opportunities, but investors should monitor margin improvement and execution against guidance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Mongodb Inc
Founded in 2007, MongoDB is a document-oriented database with nearly 33,000 paying customers and well past 1.5 million free users. MongoDB provides both licenses as well as subscriptions as a service for its NoSQL database. MongoDB's database is compatible with all major programming languages and is capable of being deployed for a variety of use cases.
Read more on MDB →
